Vinvik Pharma Private Limited
Founded in 2002 and headquartered in Haryana, India.
2002 | Gurugram, Haryana (India) | Active
Vinvik Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.10 M
- Company Age 22 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Revenue Growth -4.50%
- Profit Growth -32.43%
- Ebitda 12.74%
- Net Worth 16.20%
- Total Assets 30.74%
About Vinvik Pharma
Vinvik Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 2002 and has a history of 22 years and three months. Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Vikas Bansal, Rashmi Goyal, and Ram Gupta serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239HR2002PTC034990
- Company No.
034990
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Nov 2002
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Trading
Who are the key members and board of directors at Vinvik Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Bansal  | Director | 14-Nov-2002 | Current |
| Rashmi Goyal | Additional Director | 02-Jun-2008 | Current |
| Ram Gupta | Additional Director | 02-Jun-2008 | Current |
Financial Performance of Vinvik Pharma.
Vinvik Pharma Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.5% decrease. The company also saw a substantial fall in profitability, with a 32.43% decrease in profit. The company's net worth Soared by an impressive increase of 16.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vinvik Pharma?
In 2017, Vinvik Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0.50 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Oct 2022 | Others | ₹0.50 M | Open |
How Many Employees Work at Vinvik Pharma?
Unlock and access historical data on people associated with Vinvik Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vinvik Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vinvik Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
